ROYAL BANK OF CANADA - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 55 filers reported holding CYTOSORBENTS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$14,000
-26.3%
7,529
+45.5%
0.00%
Q2 2023$19,000
+137.5%
5,173
+104.0%
0.00%
Q1 2023$8,000
+60.0%
2,536
-15.5%
0.00%
Q4 2022$5,000
-44.4%
3,000
-52.8%
0.00%
Q3 2022$9,000
-18.2%
6,356
+30.9%
0.00%
Q2 2022$11,000
+10.0%
4,856
+60.1%
0.00%
Q1 2022$10,000
-81.8%
3,034
-76.9%
0.00%
Q4 2021$55,000
-25.7%
13,108
+43.4%
0.00%
Q3 2021$74,000
+27.6%
9,140
+16.8%
0.00%
Q2 2021$58,000
-4.9%
7,823
+12.0%
0.00%
Q1 2021$61,000
+32.6%
6,983
+18.9%
0.00%
Q4 2020$46,000
+84.0%
5,872
+85.9%
0.00%
Q3 2020$25,000
-60.9%
3,159
-51.2%
0.00%
Q2 2020$64,000
-5.9%
6,479
-26.8%
0.00%
Q1 2020$68,000
+209.1%
8,857
+51.9%
0.00%
Q4 2019$22,000
-8.3%
5,830
+26.7%
0.00%
Q3 2019$24,000
+14.3%
4,600
+47.3%
0.00%
Q2 2019$21,000
-40.0%
3,122
-32.1%
0.00%
Q1 2019$35,000
-5.4%
4,600
-0.2%
0.00%
Q4 2018$37,000
-54.9%
4,610
-27.9%
0.00%
Q3 2018$82,000
+51.9%
6,395
+33.1%
0.00%
Q2 2018$54,000
+74.2%
4,803
+9.2%
0.00%
Q1 2018$31,000
-18.4%
4,400
-25.1%
0.00%
Q4 2017$38,000
+123.5%
5,874
+109.4%
0.00%
Q3 2017$17,000
+112.5%
2,805
+55.8%
0.00%
Q2 2017$8,000
-57.9%
1,800
-58.1%
0.00%
Q1 2017$19,000
+18.8%
4,300
+48.3%
0.00%
Q4 2016$16,000
-27.3%
2,900
-17.1%
0.00%
Q3 2016$22,000
+450.0%
3,500
+337.5%
0.00%
Q2 2016$4,000
+33.3%
8000.0%0.00%
Q1 2016$3,000
-25.0%
8000.0%0.00%
Q4 2015$4,000
-20.0%
8000.0%0.00%
Q3 2015$5,0000.0%8000.0%0.00%
Q2 2015$5,000
-54.5%
8000.0%0.00%
Q1 2015$11,000
+37.5%
8000.0%0.00%
Q4 2014$8,0008000.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders